Clinical Trial Update: "The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients" [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating memantine to prevent or lessen paclitaxel-induced toxicity in breast cancer patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Memantine (memantine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Ain Shams University | Conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Phase 2 | Status: RECRUITING